Aria Vaishnavi, PhD
机构: Assistant Professor, University of Texas MD Anderson Cancer Center
每年引用次数
引用次数
引用: 2,516
H-指数: 10
I10-指数 : 12
出版物: 26
Oncogenic fusion kinases in lung cancer
Aria Vaishnavi
University of Colorado Anschutz Medical Campus. Strauss Health Sciences Library
2017
Abstract A29: The CUTO panel of patient-derived NSCLC cell lines reveals unique molecular characteristics and responses to targeted therapies
Anh Tuan Le , Adriana Estrada-Bernal , Laura Schubert , Andrea Doak
Clinical Cancer Research 24
2018
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
Doron Lipson , Philip J Stephens , Vince A Miller , Marileila Varella-Garcia
Nature Medicine 19 ( 11) 1469 -1472
402
2013
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
Gorjan Hrustanovic , Victor Olivas , Evangelos Pazarentzos , Asmin Tulpule
Nature Medicine 21 ( 9) 1038 -1047
257
2015
TRKing Down an Old Oncogene in a New Era of Targeted Therapy
Aria Vaishnavi , Anh T. Le , Robert C. Doebele
Cancer Discovery 5 ( 1) 25 -34
535
2015
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
Robert C. Doebele , Lara E. Davis , Aria Vaishnavi , Anh T. Le
Cancer Discovery 5 ( 10) 1049 -1057
227
2015
EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.
Aria Vaishnavi , Laura Schubert , Uwe Rix , Lindsay A. Marek
Cancer Research 77 ( 13) 3551 -3563
40
2017
NTRK1 gene fusions as a novel oncogene target in lung cancer.
Robert Charles Doebele , Aria Vaishnavi , Marzia Capelletti , Anh T Le
Journal of Clinical Oncology 31 8023 -8023
17
2013
Analysis of NTRK1 gene fusion incidence in an unselected cohort of non-small cell lung cancer patients.
Robert Charles Doebele , Severine Kako , Anh T Le , Marcos da Costa Silva
Journal of Clinical Oncology 32 ( 15_suppl) 8048 -8048
2014
Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer.
Aria Vaishnavi , Michael T. Scherzer , Conan G. Kinsey , Gennie L. Parkman
Cell Reports 32 ( 5) 107994
1
2020
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer
Kurtis D. Davies , Sakshi Mahale , David P. Astling , Dara L. Aisner
PLOS ONE 8 ( 12)
88
2013
Abstract B29: Oncogenic K-ras addiction in NSCLC switches PKCδ from a pro-apoptotic to a pro-survival signal
Angela M. Ohm , Aria Vaishnavi , Jennifer Symonds , Mary E. Reyland
Clinical Cancer Research 18
2012
Transposon mutagenesis reveals RBMS3 silencing as a promoter of malignant progression of BRAFV600E-driven lung tumorigenesis
Aria Vaishnavi , Joseph Juan , Maebh Jacob , Christopher Stehn
Cancer research 82 ( 22) 4261 -4273
1
2022
Transposon Mutagenesis Reveals RBMS3 as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis
Aria Vaishnavi , Joseph Juan , Michael T Scherzer , J Edward VanVeen
bioRxiv 2022 -02
2022
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape
David Planchard , Rachel E Sanborn , Marcelo V Negrao , Aria Vaishnavi
NPJ Precision Oncology 8 ( 1) 90 -90
2024
Adaptive Survival Signaling in Oncogenic Fusion Kinase Addicted NSCLC
Aria Vaishnavi , Stephen B Keysar , Anh T Le , Dara L Aisner
JOURNAL OF THORACIC ONCOLOGY 10 ( 9) S214 -S214
1
2015
The CUTO panel of patient-derived NSCLC cell lines reveals unique molecular characteristics and responses to targeted therapies
Anh Tuan Le , Adriana Estrada-Bernal , Laura Schubert , Andrea Doak
CLINICAL CANCER RESEARCH 24 ( 17)
2018
EGFR is a conspiring kinase in gene fusion positive lung cancer
Aria Vaishnavi , Anh T Le , Stephen B Keysar , Christine M Lovly
Cancer Research 74 ( 19_Supplement) 5255 -5255
2014
Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse
Aria Vaishnavi , Conan G Kinsey , Martin McMahon
Cold Spring Harbor Perspectives in Medicine 14 ( 1) a041385 -a041385
1
2024
Combined TRKA and MEK1/2 Inhibition Forestalls the Onset of Acquired Resistance in a New Preclinical Model of NTRK1+ Pancreatic Cancer
Aria Vaishnavi , Michael T Scherzer , Conan Kinsey , Ignacio Garrido-Laguna
Cancer Research 80 ( 16_Supplement) 3769 -3769
2020